Doctor profile · Federal record

Dr. Amanda Vantrease, MSN, ACNP-BC

Acute Care Nurse Practitioner (CMS: Nurse Practitioner) · Nashville, TN

  • NPI 1619240413
  • Accepts Medicare
  • 16 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
250 25Th Ave N, Ste 100
Nashville, TN 372031632
(615) 320-5090
fax (615) 320-1225
Mailing address
Po Box 440100
Nashville, TN 372440100

Credentials & registration

NPPES · NUCC
NPI registered
February 2012 — 14 yrs on file
Profile last updated
April 11, 2012
Year of graduation
2010 — 16 yrs since
Specialty taxonomy
363LA2100X — NUCC code
State license (1)
Tennessee #15785

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1619240413. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
44,118
Distinct HCPCS
10
Medicare allowed
$93,971
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 42,000 34 $1
J0897 Injection, denosumab, 1 mg 1,620 14 $24
J1100 Injection, dexamethasone sodium phosphate, 1 mg 212 14 $0
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 85 52 $48
96372 Injection of drug or substance under skin or into muscle 48 29 $11
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 36 13 $16
96375 Injection of additional new drug or substance into vein 28 12 $12
99213 Established patient office or other outpatient visit, 20-29 minutes 27 27 $69
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 26 13 $22
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional 19 18 $18

In context: peer comparison

Among 129 peers in this city , average services per provider: 198. This provider delivers 223× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,898
Transactions
56
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
PFIZER INC. 10 $230.18
Novartis Pharmaceuticals Corporation 7 $163.59
Pharmacosmos Therapeutics Inc. 3 $161.38
Merck Sharp & Dohme LLC 5 $140.28
Janssen Biotech, Inc. 4 $111.51
ABBVIE INC. 4 $99.46
AstraZeneca Pharmaceuticals LP 5 $98.64
Regeneron Healthcare Solutions, Inc. 3 $81.69
Celgene Corporation 3 $77.73
Eisai Inc. 3 $76.84
Gilead Sciences, Inc. 2 $52.10
Daiichi Sankyo Inc. 2 $50.58
Takeda Pharmaceuticals U.S.A., Inc. 2 $47.28
PharmaEssentia USA Corporation 2 $44.50
Blueprint Medicines Corporation 1 $42.03

By nature of payment

Food and Beverage
$1,803
Education
$95

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
213
Patients
11
Total drug cost
$353,633
Drug Type Claims Patients Total cost
Gabapentin Generic 34 0 $614
Anastrozole Generic 23 0 $592
Imbruvica (Ibrutinib) Brand 23 0 $342,668
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 18 0 $382
Acyclovir Generic 16 0 $166
Diphenoxylate-Atropine (Diphenoxylate Hcl/Atropine) Brand 16 0 $281
Potassium Chloride Generic 15 0 $168
Prochlorperazine Maleate Generic 15 11 $255
Letrozole Generic 14 0 $436
Eliquis (Apixaban) Brand 13 0 $7,879

Frequently asked questions

Auto-generated from federal data
What is Dr. Amanda Vantrease's medical specialty?
Dr. Amanda Vantrease practices Acute Care Nurse Practitioner in Nashville, TN.
Where does Dr. Amanda Vantrease practice?
Dr. Amanda Vantrease practices at 250 25Th Ave N, Nashville, TN 372031632. Office phone: 6153205090.
What is Dr. Amanda Vantrease's NPI?
Dr. Amanda Vantrease's National Provider Identifier (NPI) is 1619240413, issued by NPPES.
Does Dr. Amanda Vantrease accept Medicare assignment?
Yes. Dr. Amanda Vantrease accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amanda Vantrease commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, denosumab, 1 mg (HCPCS J0897); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100). Source: CMS Medicare Physician & Other Practitioners file.